REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/22/2025
Back to search
Official data from USPTO
RTM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
09/23/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
12/12/2019
Registration date
09/22/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/22/2020
Last transaction
09/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
DINALLO, KEVIN
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Neurimmune Holding AG
Representatives
Janice Housey Litmus Law PLLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of nervous system diseasesinfectious diseasesneoplasmsimmune system diseasesendocrine and metabolic diseasescirculatory system diseaseseye diseases; Veterinary preparations for the treatment of nervous system diseasesinfectious diseasesneoplasmsimmune system diseasesendocrine diseasesmetabolic diseasescirculatory system diseaseseye diseases; Pharmaceutical preparations for immunotherapeutic usepharmaceutical agents for the elimination of tumorspharmaceutical preparations for the treatment of neurodegenerative diseasespharmaceutical preparationsimmunogens; Pharmaceutical preparationsantibodies used for the testing of the disease; Vaccines; Diagnostic preparations for medical use in the form of epitopes for detecting protein abnormalities; Pharmaceutical preparationssynthetic peptides used for the treatment of central nervous system diseasesmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; Hygiene preparations for medical usedisinfectants; Biocides; Diagnostic preparations for medical or veterinary use; Sanitary towels for hygiene purposes; Dietetic foods for medical use; Dietetic beverages for medical use; Biological preparations for medical use in the form of protein antibodies directed against specific protein epitopes for use in the treatment of central nervous system diseasesmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunological diseasesinflammatory diseasesrespiratory diseasespsychological diseases; Anti-bacterial preparationsanti-bacterial substances for medical useanti-bacterial pharmaceutical preparationsbio-pharmaceutical preparations for the treatment of cancer; Protein dietary supplements
Class 42
Monitoringinspection and analysis of biologically active chemicals for quality control purposes; Research in the field of pharmaceutical productscosmetics and foodstuffs for others; Advisory and information services in the field of monitoring and control for purposes of quality control and analysis of biologically active chemicals; Research in the field of medical treatment and medical methods; Research in the field of biotechnology and antibodies; Medical and scientific research in the field of clinical trial review and research with regard to medical treatment; Research in the field of sanitary care; Monitoring and inspection of biological synthesis and pharmaceutical production for quality control purposes and for purposes of scientific research and research in the field of biology; Software design; Computer programming; Maintenance of software; Design and development of computer hardware; Software development; Consultancy and providing of information with respect to quality control of pharmaceutical products; Scientific research in the field of cancerous diseases; Scientific research with respect to chemistry
Class 44
Medical services; Medical services in the field of immunity; Provision of medical information; Medical examinationsphysical examinations for medical purposes; Pharmaceutical consulting in the manufacture of medicines; Services provided by consultants in nutrition and dietetics; Consultancy and providing of information in the field of sanitary careproviding of health information in connection with health; Veterinary services; Beauty salon services; Animal care servicesveterinary care services; Medical consulting services for hygiene in the field of care; Medical consultancy and providing of medical information with respect to preparationadministration and dosing of pharmaceutical preparations; Consulting services with respect to preparation and administration of pharmaceutical products; Providing medical information for medical staff and for patients in the form of compiled reports in the field of diagnosticprophylactic and therapeutic properties of medicines; Drug testingsystematic testing of medicinal products for medical use
Publications
History of USPTO decisions and trademark events.
34 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/12/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/12/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/10/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/04/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/21/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/21/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/21/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/21/2021
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
01/23/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/01/2021
FIMP
FINAL DISPOSITION PROCESSED
01/01/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/22/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/22/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/07/2020
PUBO
PUBLISHED FOR OPPOSITION
07/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/17/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/30/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/29/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/29/2020
RFNT
REFUSAL PROCESSED BY IB
04/17/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/28/2020
RFRR
REFUSAL PROCESSED BY MPU
03/27/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/13/2020
CNRT
NON-FINAL ACTION WRITTEN
03/12/2020
DOCK
ASSIGNED TO EXAMINER
03/04/2020
MAFR
APPLICATION FILING RECEIPT MAILED
02/01/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/31/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/28/2020
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
01/23/2020
Continuous trademark protection
Get notified about every new filing that threatens RTM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.